Community-acquired Coinfection in Coronavirus Disease 2019: A Retrospective Observational Experience
Christopher Lehmann, Mai T. Pho, David Pitrak, Jessica P. Ridgway, Natasha N. Pettit
Abstract
Community-acquired coinfection in coronavirus disease 2019 (COVID-19) is not well defined. Current literature describes coinfection in 0-40% of COVID-19 patients. In this retrospective report, coinfection was identified in 3.7% of patients and 41% of patients admitted to intensive care (P < .005). Despite infrequent coinfection, antibiotics were used in 69% of patients.
Topics & Concepts
CoinfectionRetrospective cohort studyMedicineCoronavirus disease 2019 (COVID-19)DiseaseInternal medicineObservational studyCoronavirusIntensive care medicineVirologyInfectious disease (medical specialty)Human immunodeficiency virus (HIV)Antibiotic Use and ResistancePneumonia and Respiratory InfectionsAntimicrobial Resistance in Staphylococcus